These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 20112359)

  • 1. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.
    Salloum R; Franek BS; Kariuki SN; Rhee L; Mikolaitis RA; Jolly M; Utset TO; Niewold TB
    Arthritis Rheum; 2010 Feb; 62(2):553-61. PubMed ID: 20112359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
    Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
    Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
    Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
    Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a functional IRF7 variant with systemic lupus erythematosus.
    Fu Q; Zhao J; Qian X; Wong JL; Kaufman KM; Yu CY; ; ; Mok MY; Harley JB; Guthridge JM; Song YW; Cho SK; Bae SC; Grossman JM; Hahn BH; Arnett FC; Shen N; Tsao BP
    Arthritis Rheum; 2011 Mar; 63(3):749-54. PubMed ID: 21360504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus.
    Weckerle CE; Franek BS; Kelly JA; Kumabe M; Mikolaitis RA; Green SL; Utset TO; Jolly M; James JA; Harley JB; Niewold TB
    Arthritis Rheum; 2011 Apr; 63(4):1044-53. PubMed ID: 21162028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythematosus in a Japanese population.
    Kawasaki A; Furukawa H; Kondo Y; Ito S; Hayashi T; Kusaoi M; Matsumoto I; Tohma S; Takasaki Y; Hashimoto H; Sumida T; Tsuchiya N
    Lupus; 2012 Jul; 21(8):890-5. PubMed ID: 22433914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis.
    Carmona FD; Gutala R; Simeón CP; Carreira P; Ortego-Centeno N; Vicente-Rabaneda E; García-Hernández FJ; García de la Peña P; Fernández-Castro M; Martínez-Estupiñán L; Egurbide MV; Tsao BP; Gourh P; Agarwal SK; Assassi S; Mayes MD; Arnett FC; Tan FK; Martín J;
    Ann Rheum Dis; 2012 Jan; 71(1):114-9. PubMed ID: 21926187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes.
    Agik S; Franek BS; Kumar AA; Kumabe M; Utset TO; Mikolaitis RA; Jolly M; Niewold TB
    J Rheumatol; 2012 Jan; 39(1):73-8. PubMed ID: 22045845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.
    Bruner BF; Guthridge JM; Lu R; Vidal G; Kelly JA; Robertson JM; Kamen DL; Gilkeson GS; Neas BR; Reichlin M; Scofield RH; Harley JB; James JA
    Arthritis Rheum; 2012 Nov; 64(11):3677-86. PubMed ID: 23112091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
    Lin LH; Ling P; Liu MF
    J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients.
    Robinson T; Kariuki SN; Franek BS; Kumabe M; Kumar AA; Badaracco M; Mikolaitis RA; Guerrero G; Utset TO; Drevlow BE; Zaacks LS; Grober JS; Cohen LM; Kirou KA; Crow MK; Jolly M; Niewold TB
    J Immunol; 2011 Aug; 187(3):1298-303. PubMed ID: 21705624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus.
    Weckerle CE; Mangale D; Franek BS; Kelly JA; Kumabe M; James JA; Moser KL; Harley JB; Niewold TB
    Arthritis Rheum; 2012 Sep; 64(9):2947-52. PubMed ID: 22488302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic variations in the STAT4 and IRF7/KIAA1542 regions with systemic lupus erythematosus in a Northern Han Chinese population.
    Li P; Cao C; Luan H; Li C; Hu C; Zhang S; Zeng X; Zhang F; Zeng C; Li Y
    Hum Immunol; 2011 Mar; 72(3):249-55. PubMed ID: 21167895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy.
    Torell A; Stockfelt M; Blennow K; Zetterberg H; Akhter T; Leonard D; Rönnblom L; Pihl S; Saleh M; Sjöwall C; Strevens H; Jönsen A; Bengtsson AA; Trysberg E; Majczuk Sennström M; Zickert A; Svenungsson E; Gunnarsson I; Bylund J; Jacobsson B; Rudin A; Lundell AC
    Arthritis Res Ther; 2024 Mar; 26(1):65. PubMed ID: 38459582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ribosomal P antibodies are associated with elevated circulating IFNα and IL-10 levels in systemic lupus erythematosus patients.
    Mozo L; López P; Caminal-Montero L; Rodríguez-Carrio J; Suárez A
    Lupus; 2014 Dec; 23(14):1477-85. PubMed ID: 25107939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
    Chauhan SK; Singh VV; Rai R; Rai M; Rai G
    J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon regulatory factors in human lupus pathogenesis.
    Salloum R; Niewold TB
    Transl Res; 2011 Jun; 157(6):326-31. PubMed ID: 21575916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes.
    Namjou B; Kim-Howard X; Sun C; Adler A; Chung SA; Kaufman KM; Kelly JA; Glenn SB; Guthridge JM; Scofield RH; Kimberly RP; Brown EE; Alarcón GS; Edberg JC; Kim JH; Choi J; Ramsey-Goldman R; Petri MA; Reveille JD; Vilá LM; Boackle SA; Freedman BI; Tsao BP; Langefeld CD; Vyse TJ; Jacob CO; Pons-Estel B; ; Niewold TB; Moser Sivils KL; Merrill JT; Anaya JM; Gilkeson GS; Gaffney PM; Bae SC; Alarcón-Riquelme ME; ; Harley JB; Criswell LA; James JA; Nath SK
    PLoS One; 2013; 8(8):e69404. PubMed ID: 23950893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.